SCHEMBL17486017

SCHEMBL17486017

CC(=O)c1cc(Br)cnc1-c1ccc2c(c1)C(C)(C)C(C)(C)C2(C)C

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.33
KDM4E B2RXH2 3/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
OPRK1 P41145 2/20 0.33
RXFP1 Q9HBX9 2/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
DYRK1A Q13627 2/20 0.31
DYRK1B Q9Y463 1/20 0.31
TSHR P16473 1/20 0.31
HTT P42858 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
RARA P10276 1/20 0.30
RARB P10826 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17486054 0.86 NPC1 (0.37) SMN1; SMN2KDM4ENPC1RAB9AALDH1A1
SCHEMBL17486236 0.80 SMN1; SMN2 (0.35) SMN1; SMN2ALDH1A1HTT
SCHEMBL19295097 0.79 PDGFRB (0.39)
SCHEMBL17486219 0.79 ALDH1A1 (0.35) SMN1; SMN2ALDH1A1HTT
SCHEMBL17486283 0.76 IDO1 (0.35) SMN1; SMN2KDM4ENPC1RAB9AALDH1A1
SCHEMBL17486306 0.76 TRPV1 (0.34) NPC1RAB9ARARARARBRARG
SCHEMBL17486286 0.75 CYP11B1 (0.35) SMN1; SMN2ALDH1A1HTT
SCHEMBL17477823 0.75 NPC1 (0.38) SMN1; SMN2NPC1RAB9AALDH1A1NFKB1
SCHEMBL20805442 0.75 MELK (0.32)
SCHEMBL17486305 0.72 MAP4K4 (0.33) SMN1; SMN2KDM4ENPC1RAB9ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 SMN1; SMN2 3736/4885KDM4E 3816/4885NPC1 3516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.